We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adient (ADNT) Surges 17.7%: Is This an Indication of Further Gains?
Read MoreHide Full Article
Adient (ADNT - Free Report) shares ended the last trading session 17.7% higher at $47.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 9.2% gain over the past four weeks.
Notably, the firm touched a 52-week high of $47.98 on Mar 12, closing the session a tad lower at $47.47, reflecting a jump of 17.7%. The stock rallied following the company’s decision to sell stake in its Yanfeng JV in China for $1.5 billion. The deal, set for closure in the second half of 2021, will allow Adient to navigate China's automotive market independently and position the company for further growth in the nation.
Price and Consensus
This automotive seating and interiors supplier is expected to post quarterly earnings of $0.60 per share in its upcoming report, which represents a year-over-year change of -3.2%. Revenues are expected to be $3.68 billion, up 4.8% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Adient, the consensus EPS estimate for the quarter has been revised 7.6% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on ADNT going forward to see if this recent jump can turn into more strength down the road.
Image: Bigstock
Adient (ADNT) Surges 17.7%: Is This an Indication of Further Gains?
Adient (ADNT - Free Report) shares ended the last trading session 17.7% higher at $47.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 9.2% gain over the past four weeks.
Notably, the firm touched a 52-week high of $47.98 on Mar 12, closing the session a tad lower at $47.47, reflecting a jump of 17.7%. The stock rallied following the company’s decision to sell stake in its Yanfeng JV in China for $1.5 billion. The deal, set for closure in the second half of 2021, will allow Adient to navigate China's automotive market independently and position the company for further growth in the nation.
Price and Consensus
This automotive seating and interiors supplier is expected to post quarterly earnings of $0.60 per share in its upcoming report, which represents a year-over-year change of -3.2%. Revenues are expected to be $3.68 billion, up 4.8% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Adient, the consensus EPS estimate for the quarter has been revised 7.6% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on ADNT going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank 2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>